あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/03/10 | 2,200 | 2,238 | 2,200 | 2,214 | +14 | +0.6% | 36,800 |
| 2025/03/07 | 2,160 | 2,209 | 2,160 | 2,200 | +30 | +1.4% | 75,200 |
| 2025/03/06 | 2,165 | 2,180 | 2,162 | 2,170 | +24 | +1.1% | 38,200 |
| 2025/03/05 | 2,150 | 2,185 | 2,125 | 2,146 | +47 | +2.2% | 59,400 |
| 2025/03/04 | 2,082 | 2,112 | 2,080 | 2,099 | +24 | +1.2% | 49,500 |
| 2025/03/03 | 2,080 | 2,100 | 2,059 | 2,075 | +45 | +2.2% | 51,300 |
| 2025/02/28 | 1,999 | 2,034 | 1,997 | 2,030 | +42 | +2.1% | 79,400 |
| 2025/02/27 | 1,969 | 1,994 | 1,962 | 1,988 | +19 | +1% | 36,700 |
| 2025/02/26 | 1,944 | 1,969 | 1,939 | 1,969 | +25 | +1.3% | 45,400 |
| 2025/02/25 | 1,919 | 1,944 | 1,900 | 1,944 | +18 | +0.9% | 44,100 |
| 2025/02/21 | 1,967 | 1,967 | 1,920 | 1,926 | -22 | -1.1% | 41,900 |
| 2025/02/20 | 1,953 | 1,966 | 1,935 | 1,948 | -15 | -0.8% | 37,900 |
| 2025/02/19 | 1,962 | 1,969 | 1,946 | 1,963 | +13 | +0.7% | 34,700 |
| 2025/02/18 | 1,938 | 1,959 | 1,929 | 1,950 | +12 | +0.6% | 32,300 |
| 2025/02/17 | 1,943 | 1,964 | 1,934 | 1,938 | -36 | -1.8% | 22,200 |
| 2025/02/14 | 1,965 | 1,981 | 1,964 | 1,974 | +4 | +0.2% | 32,800 |
| 2025/02/13 | 1,940 | 1,970 | 1,938 | 1,970 | +48 | +2.5% | 31,300 |
| 2025/02/12 | 1,940 | 1,940 | 1,917 | 1,922 | ±0 | ±0% | 35,500 |
| 2025/02/10 | 1,922 | 1,947 | 1,922 | 1,922 | ±0 | ±0% | 26,500 |
| 2025/02/07 | 1,933 | 1,940 | 1,917 | 1,922 | +22 | +1.2% | 32,500 |
| 2025/02/06 | 1,895 | 1,910 | 1,876 | 1,900 | +15 | +0.8% | 38,000 |
| 2025/02/05 | 1,885 | 1,885 | 1,852 | 1,885 | +29 | +1.6% | 49,400 |
| 2025/02/04 | 1,849 | 1,907 | 1,825 | 1,856 | -33 | -1.7% | 137,100 |
| 2025/02/03 | 1,930 | 1,931 | 1,842 | 1,889 | -78 | -4% | 149,200 |
| 2025/01/31 | 1,986 | 1,986 | 1,954 | 1,967 | +8 | +0.4% | 37,200 |
| 2025/01/30 | 1,970 | 1,978 | 1,953 | 1,959 | -4 | -0.2% | 37,800 |
| 2025/01/29 | 1,978 | 1,982 | 1,963 | 1,963 | -23 | -1.2% | 45,900 |
| 2025/01/28 | 1,972 | 1,989 | 1,970 | 1,986 | +14 | +0.7% | 42,100 |
| 2025/01/27 | 1,967 | 1,974 | 1,953 | 1,972 | +32 | +1.6% | 70,400 |
| 2025/01/24 | 1,948 | 1,967 | 1,930 | 1,940 | -2 | -0.1% | 79,600 |
| 2025/01/23 | 1,952 | 1,952 | 1,933 | 1,942 | -20 | -1% | 88,500 |
| 2025/01/22 | 1,991 | 1,995 | 1,945 | 1,962 | ±0 | ±0% | 74,600 |
| 2025/01/21 | 1,960 | 1,969 | 1,952 | 1,962 | +22 | +1.1% | 67,500 |
| 2025/01/20 | 1,934 | 1,949 | 1,927 | 1,940 | +18 | +0.9% | 81,600 |
| 2025/01/17 | 1,931 | 1,936 | 1,913 | 1,922 | -13 | -0.7% | 59,200 |
| 2025/01/16 | 1,948 | 1,949 | 1,927 | 1,935 | -13 | -0.7% | 85,700 |
| 2025/01/15 | 1,964 | 1,972 | 1,937 | 1,948 | -20 | -1% | 62,400 |
| 2025/01/14 | 1,987 | 2,000 | 1,951 | 1,968 | -30 | -1.5% | 50,300 |
| 2025/01/10 | 2,011 | 2,015 | 1,990 | 1,998 | -20 | -1% | 39,700 |
| 2025/01/09 | 2,026 | 2,031 | 2,000 | 2,018 | +3 | +0.1% | 46,800 |
| 2025/01/08 | 2,038 | 2,049 | 2,007 | 2,015 | -23 | -1.1% | 48,100 |
| 2025/01/07 | 2,080 | 2,080 | 2,038 | 2,038 | -40 | -1.9% | 59,600 |
| 2025/01/06 | 2,105 | 2,113 | 2,078 | 2,078 | -21 | -1% | 53,200 |
| 2024/12/30 | 2,108 | 2,118 | 2,090 | 2,099 | -1 | ±0% | 47,600 |
| 2024/12/27 | 2,080 | 2,100 | 2,074 | 2,100 | +18 | +0.9% | 50,700 |
| 2024/12/26 | 2,064 | 2,082 | 2,053 | 2,082 | +23 | +1.1% | 43,200 |
| 2024/12/25 | 2,100 | 2,103 | 2,041 | 2,059 | -6 | -0.3% | 71,800 |
| 2024/12/24 | 2,066 | 2,074 | 2,059 | 2,065 | ±0 | ±0% | 39,300 |
| 2024/12/23 | 2,060 | 2,068 | 2,050 | 2,065 | +15 | +0.7% | 38,800 |
| 2024/12/20 | 2,040 | 2,060 | 2,040 | 2,050 | +14 | +0.7% | 33,000 |
51～
100
件表示中 / 1013件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 235,000円 | +16.9% | +33.2% | 2.34% | 12.82倍 | 1.02倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 81,800円 | +20.3% | - | 0.00% | 145.04倍 | 1.08倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 45,100円 | +14.3% | - | 4.43% | 18.32倍 | 1.17倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| タウンズ | 55,200円 | +4.6% | +6.1% | 5.07% | 9.40倍 | 3.48倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム
